CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park

Cancer Research and Treatment. 2018;50(4):1252-1259. Published online 2018 January 2 DOI: https://doi.org/10.4143/crt.2017.438

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park

Cancer Research and Treatment. 2018;50(4):1252-1259

Link1

Link2 Link3

A phase II study of TKI258 in patients with castration-resistant prostate cancer (KCSG-GU11-05)

Y.J. Choi, H.S. Kim, S.H. Park, B.S. Kim, K.H. Kim, H.J. Lee, H.S. Song, D.Y. Shin, H.Y. Lee, H.-G. Kim, K.H. Lee, J.-L. Lee, K.H. Park

Annals of Oncology. 2016;27:vi249

Link1 Link2 Link3

Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study

David O’Reilly

Clinical Genitourinary Cancer. 2019;17(5):e886-e887

Link1 Link2

Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer

Robert J. Amato, L. Michael Glode, Jeremy Podolnick, Robert Knight, David Crawford

Cancers. 2011;3(3):3449-3460

Link1

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

T M Beer, D C Smith, A Hussain, M Alonso, J Wang, M Giurescu, K Roth, Y Wang

British Journal of Cancer. 2012;107(5):808-813

Link1

Link2 Link3

Castration Resistant Prostate Cancer: Role of Chemotherapy

Marijo Bilusic

Prostate Cancer. 2016;509-514

Link1 Link2

Options After Chemotherapy for Patients with Metastatic, Castration-Resistant Prostate Cancer

Daniel J. Lee, Neal D. Shore

Prostate Cancer. 2018;121-134

Link1

Exploratory Study of [18F]fluciclovine PET/CT for Response Assessment to Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer

. 2021;

Link1 Link2

Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill, Philippe Beuzeboc

BJU International. 2010;106(7):974-978

Link1

Editorial Comment on: A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Castration-Resistant Prostate Cancer

Henk G. van der Poel

European Urology. 2009;56(1):103-104

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.